Plain-English translation of NCT07865377 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether resveratrol, a natural compound found in plants like grapes and berries, might help protect the hearts of postmenopausal women with coronary artery disease. Researchers want to see if this medication affects hormones and certain proteins in your body that are important for heart health. You'll take either the real supplement or a placebo (a dummy pill) every day for 90 days.
After menopause, women lose natural hormone protection that helps keep their hearts healthy, and heart disease becomes a leading health risk. Scientists believe this medication might work by acting like an antioxidant—fighting damage in your blood vessels and supporting the natural processes your body uses to protect itself.
You likely qualify if…
You likely don't qualify if…
You'll visit the clinic at the start, then at 30, 60, and 90 days. At your first and final visits, you'll have blood tests and nutritional assessments. Every day for 3 months, you'll take one capsule of either the supplement or a placebo—you won't know which one. The study team will check in on how you're doing and how your body is responding to the treatment.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Brazil
Sponsor
InCor Heart Institute
Enrollment target
~80 participants
Started
August 2026
Primary completion
August 2029
Age range
45 Years – 70 Years
Sex
Female only
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Antonio de Padua Mansur, PhD
InCor Heart Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.